This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Investcorp and the Moneybookers Bid
Rhodes-Kropf, Matthew; Knoop, Carin-Isabel; Lietz, Nori GerardoCase HBS-811013-EEntrepreneurshipIn January 2007, Hazem Ben-Gacem, managing director and co-head of Investcorp Technology Partners (ITP), needs to decide what to bid at an auction for Moneybookers Limited, one of the top three e-payment solution providers in Europe. However, approximately 70% of Moneybookers revenues were related to transactions from online gaming sites (down from 100% in 2002). Although the thesis was that e-commerce transactions would soon make up a much large...Starting at €8.20
-
Miracle Life, Inc. (Spanish version)
Cohen, Lauren H.; Malloy, Christopher J.Case HBS-218S08FinanceMilagro La vida es una empresa con una configuración única y la estructura organizativa. En concreto, se trata de una empresa de marketing de red (también conocido como marketing multinivel (MLM) empresa), que utiliza una gran base de distribuidores, y depende de esta base de distribuidores individuales para vender sus productos, dando incentivos explícitos para estos distribuidores individuales a la vez vender sus productos e inscribirse otros d...Starting at €8.20
-
Grove Street Advisors: September 2009
Rhodes-Kropf, Matthew; Leamon, AnnCase HBS-810064-EFinanceThe investment committee of Grove Street Advisors, a pioneer in the provision of customized private equity funds-of-funds for pension fund clients, must decide how to respond to the market opportunities and challenges presented by the turmoil of 2008 and 2009. How can they shift their strategy to fill new market niches, or should they stay with their successful approach thus far, even though the market is getting crowded? The case also presents b...Starting at €8.20
-
The Power of Alumni Networks
Cohen, Lauren H.; Malloy, Christopher J.Article HBS-F1010D-ELeadership and People ManagementAfter analyzing more than 15 years' worth of investment data, the authors have found one way that information gets around and improves investing performance: through alumni networks.Starting at €8.20
-
Wall Street Doesn't Understand Innovation
Malloy, Christopher J.Article HBS-F1212D-EThough innovation is critical to a company's growth, investors don't seem to factor companies' strength or weakness at R&D into decisions to buy stock.Starting at €8.20
-
Iris Running Crane: December 2009
Rhodes-Kropf, Matthew; Lerner, Josh; Leamon, AnnCase HBS-810073-EEntrepreneurshipIris Running Crane, an MBA candidate, must choose among three different job offers in private equity. One is with a top-tier megafund buyout operation; the second with a geographically focused mid-market fund; and the third with a one-time top-tier fund that is trying to reposition itself as a turnaround expert, starting with its own portfolio. Iris must consider the advantages and drawbacks of each position, and how each will help her achieve he...Starting at €8.20
-
Grove Street Advisors: September 2009, Teaching Note
Rhodes-Kropf, Matthew; Leamon, AnnTeaching Note HBS-812094-EFinanceTeaching Note for 810-064.Starting at €0.00
-
Investcorp and the Moneybookers Bid, Teaching Note
Rhodes-Kropf, Matthew; Lobb, AnnelenaTeaching Note HBS-814093-EEntrepreneurshipTeaching Note for 811013.Starting at €0.00
-
VCPE Strategy Vignettes I, II, and 2012, Teaching Note
Rhodes-Kropf, Matthew; Burbank, NathanielTeaching Note HBS-814086-EEntrepreneurshipTeaching Note for 811043, 811054, and 812073.Starting at €0.00
-
Avid Radiopharmaceuticals: The Venture Debt Question
Rhodes-Kropf, Matthew; Leamon, AnnCase HBS-809086-EEntrepreneurshipThe CEO of a promising biotech company must decide how to respond to the macro-economic slump of late 2008. He had planned to pursue an aggressive schedule moving the firm's Alzheimer's and Parkinson's disease imaging compounds through clinical trials and into the market. This involved expanding the firm's facilities and headcount and he planned to fund this by taking venture debt. Although clinical trial data is extremely encouraging, questions ...Starting at €8.20